Shopping Cart
- Remove All
- Your shopping cart is currently empty
DOCK2-IN-1, an analogue of CPYPP, effectively inhibits DOCK2 (IC50 = 19.1 μM) by reversibly binding to its DHR-2 domain, thereby hindering its catalytic function. This compound obstructs the activation of Rac in lymphocytes, triggered either by chemokine or antigen receptors. Consequently, DOCK2-IN-1 markedly reduces chemotactic responses and T cell activation [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $613 | 6-8 weeks | |
50 mg | $797 | 6-8 weeks | |
100 mg | $1,210 | 6-8 weeks |
Description | DOCK2-IN-1, an analogue of CPYPP, effectively inhibits DOCK2 (IC50 = 19.1 μM) by reversibly binding to its DHR-2 domain, thereby hindering its catalytic function. This compound obstructs the activation of Rac in lymphocytes, triggered either by chemokine or antigen receptors. Consequently, DOCK2-IN-1 markedly reduces chemotactic responses and T cell activation [1]. |
Molecular Weight | 298.72 |
Formula | C16H11ClN2O2 |
Cas No. | 4590-86-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.